Press Releases
GSK announces global restructuring plan, laying off over 1,200 people in Belgium
Global pharmaceutical giant GSK announced a $2.5 billion global restructuring plan, laying off over 1,200 employees in Belgium, aiming to reallocate capital and resources.
GSK has announced a $2.5 billion global restructuring plan to optimize its business structure. These restructuring measures have been implemented in the Belgian region, with plans to lay off over 1,200 employees. The new layoff plan will affect employees at GSK's facilities in Rixensart, Wavre, and Gembloux.
This layoff action is part of a three-year strategic plan by the company, aimed at reallocating capital and resources to the pharmaceutical company's later-stage pipelines and R&D work. This move follows GSK's announcement to close its German vaccine manufacturing facility and lay off approximately 650 employees.
In the Belgian region, the background for the layoffs is the company's adjustment of operations and resources. This series of adjustments is intended to strengthen the company's strategic focus and ensure the effectiveness of its R&D investments.
The company stated that these adjustments are part of its long-term strategic planning, aimed at strategically reallocating capital and resources to support its core R&D areas.
Context ledger · corpwire
corpwire frames this note through Press Releases / Corporate Announcements / Financial Updates (dates, names and status changes still need checking). Source links should be opened before the summary is reused; Press Releases / Corporate Announcements / Financial Updates explains the local editorial angle.